S. 2082 The American Made Pharmaceuticals Act
Drug Pricing Reform
Issues related to FDA Inspections
Issues related to drug shortages and the pharmaceutical supply chain
S.1339 The Pharmacy Benefit Manger Reform Act
Issues related to coverage of Biosimilars within Medicare Part D
S. 2082 The American Made Pharmaceuticals Act
Drug Pricing Reform
Issues related to FDA Inspections
Issues related to reform of pharmacy benefit managers
Issues related to drug shortages and the pharmaceutical supply chainS.
S. 1339 The Pharmacy Benefit Manger Reform Act
Issues related to coverage of Biosimilars within Medicare Part D
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: U.S. Senate, Health & Human Services - Dept of (HHS), House of Representatives, White House Office, Office of Management & Budget (OMB)
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Legislative Assistant, Senator Lieberman. May 2011-June 2012
Senior Legislative Assistant, Representative Dan Boren July 2008-June 2011
Legislative Assistant. Senator Lieberman May 2011-June 2012
Senior Legislative Assistant. Representative Dan Boren. July 2008-June 2011
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate